Skip to main content
Clinical Trials/NCT02224469
NCT02224469
Completed
Not Applicable

Utrecht Neural Prosthesis (UNP): A Pilot Study on Controllability of Brain Signals and Application in locked-in Patients

UMC Utrecht1 site in 1 country6 target enrollmentSeptember 9, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Locked-In Syndrome
Sponsor
UMC Utrecht
Enrollment
6
Locations
1
Primary Endpoint
Number of Participants Reaching Proficiency Level 2: Unsupervised BCI Performance
Status
Completed
Last Updated
5 months ago

Overview

Brief Summary

In this study a new means of communication for people with locked-in syndrome will be tested. The investigators will record brain signals directly from the surface of the brain by means of a completely implantable system. These brain signals are fed wirelessly into an assistive technology device and will control this device for communication and environmental control at the users home.

Detailed Description

In this pilot study we will provide locked-in people with a new means of communication which has not been possible up to now. For the first time, we will test whether we can record and decode neural signals obtained directly from the brain, for control over a computer. The target population is people with locked-in syndrome. For these patients there is no technique available to allow them to communicate unaided. We have developed a brain-computer interface (BCI) system that can read activity directly from the brain, and can convert the activity to a digital switch. The system, called the Utrecht Neural Prosthesis (UNP), consists of an implantable amplifier for electrical brain signals, a set of electrodes positioned on the surface of the brain and a wireless receiver, placed outside of the body. A dedicated computer will convert the signals to electrical pulses for standard Assistive Technology devices. The UNP can in principle enable the patient to engage in any activity that is offered by commercial Assistive Technology companies that can be performed with switch signals, for instance operating home apparatus or writing text. Most importantly, we aim to achieve unsupervised function of the BCI, meaning that the patient will be able to use it at home without the aid of researchers or other experts (but with minimal caregiver assistance).

Registry
clinicaltrials.gov
Start Date
September 9, 2015
End Date
February 14, 2024
Last Updated
5 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Erik Aarnoutse, PhD

Study Coordinator

UMC Utrecht

Eligibility Criteria

Inclusion Criteria

  • Age 18 - 75
  • Locked-in status (i.e. severely paralyzed with communication problems)
  • in case of trauma or stroke: at least 1 year after the event
  • in case of a neuromuscular disease: slow progression allowed
  • Rudimentary form of communication possible (e.g. through assistive technology, eye blinks or eye movements, severely impaired speech)
  • Mentally and physically capable of giving informed consent
  • Lives in or close to the Netherlands
  • MR compatible
  • able to lie flat in the scanner
  • no metal objects in or attached to the body

Exclusion Criteria

  • Strong and frequent spasms
  • Vital indication for blood thinners
  • Current brain tumor or history of tumor resection
  • Quick medical or neurological deterioration
  • Patients who are considered legally incapable (and who therefore will not be able to give informed consent)
  • Current or recent psychiatric disorder
  • Catabolic state
  • Allergy to the materials of the implant

Outcomes

Primary Outcomes

Number of Participants Reaching Proficiency Level 2: Unsupervised BCI Performance

Time Frame: up to 1 year

The system correctly detects a switch brain signal within 10 sec in a real life, cognitively engaging context, such as operating a spelling device. A formal test has been designed, in which the patient has to copy a 30 character sentence within 30 minutes, with a margin of 20% faulty characters.

Secondary Outcomes

  • Patient Device Satisfaction(8 years)
  • Effects Device on Quality of Life(3 years)
  • Quality of Life by Scoring Subjective Well-being in ACSA Score(4.5 years)
  • Hours of Use of BCI Device Per Day(Time frame starts when participant receives a system with the full feature set for 24h home use and ends when signal decline starts influencing hours of use per day, an average of 1 year)

Study Sites (1)

Loading locations...

Similar Trials